SMS Pharma Ltd Announces Successful Completion Of USFDA Inspection At Its Testing Facility

SMS Pharmaceuticals Ltd has announced the successful completion of regulatory inspection by the United States Food and Drug Administration (USFDA) at its exclusive testing facility, SMS Pharmaceuticals Limited (Central Laboratory Analytical Services) during 02nd March 2020 to 06th March 2020. The regulatory audit resulted in zero observation.

The Company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all our manufacturing & Analytical facilities. The ‘Central Laboratory Analytical Services’ is our independent testing laboratory, and this was the first U.S.FDA inspection concluded with ZERO observations.

Shares of SMS PHARMACEUTICALS LTD. was last trading in BSE at Rs.36.95 as compared to the previous close of Rs. 38. The total number of shares traded during the day was 329 in over 21 trades.

The stock hit an intraday high of Rs. 37.1 and intraday low of 36.05. The net turnover during the day was Rs. 11931.-Equity Bulls